Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Servier
Washington University School of Medicine
University of Florida
Children's Oncology Group
Nuvation Bio Inc.
Dana-Farber Cancer Institute
Universität Münster
The Cooper Health System
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Novartis
University Hospital Heidelberg
Hospices Civils de Lyon
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Incyte Corporation
Jazz Pharmaceuticals
University of Florida
University of Miami
Dartmouth-Hitchcock Medical Center
City of Hope Medical Center
Novartis
Virginia Commonwealth University
Virginia Commonwealth University
Eastern Cooperative Oncology Group
Mayo Clinic
Brigham and Women's Hospital
NRG Oncology
Columbia University
Emory University
University of Oklahoma
University of Nebraska
Thomas Jefferson University
Dawonmedax Co., Ltd.
Rigel Pharmaceuticals
Oslo University Hospital
Oblato, Inc.
Grupo Español de Investigación en Neurooncología
University of California, San Francisco
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
Washington University School of Medicine
Wake Forest University Health Sciences
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
University of California, San Francisco
St. Jude Children's Research Hospital
Istari Oncology, Inc.